Correlation Between Salarius Pharmaceuticals and Aileron Therapeutics
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and Aileron Therapeutics, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Aileron Therapeutics.
Diversification Opportunities for Salarius Pharmaceuticals and Aileron Therapeutics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Salarius and Aileron is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Aileron Therapeutics go up and down completely randomly.
Pair Corralation between Salarius Pharmaceuticals and Aileron Therapeutics
Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to generate 5.79 times more return on investment than Aileron Therapeutics. However, Salarius Pharmaceuticals is 5.79 times more volatile than Aileron Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Aileron Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 180.00 in Salarius Pharmaceuticals on November 5, 2024 and sell it today you would earn a total of 35.00 from holding Salarius Pharmaceuticals or generate 19.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 26.32% |
Values | Daily Returns |
Salarius Pharmaceuticals vs. Aileron Therapeutics
Performance |
Timeline |
Salarius Pharmaceuticals |
Aileron Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Salarius Pharmaceuticals and Aileron Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Salarius Pharmaceuticals and Aileron Therapeutics
The main advantage of trading using opposite Salarius Pharmaceuticals and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics |
Aileron Therapeutics vs. Bio Path Holdings | Aileron Therapeutics vs. Benitec Biopharma Ltd | Aileron Therapeutics vs. Artelo Biosciences | Aileron Therapeutics vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |